Bluejay Diagnostics (BJDX) Short-Term Debt issuances (2021)
Bluejay Diagnostics (BJDX) posted Short-Term Debt issuances of $725.0 for Q2 2021, up 107.46% sequentially from -$9725.0 in Q1 2021.
Bluejay Diagnostics (BJDX) Short-Term Debt issuances (2021) Analysis & Trends
Bluejay Diagnostics has reported Short-Term Debt issuances for 1 years, with the latest figure at $725.0 in Q2 2021.
- Quarterly Short-Term Debt issuances changed N/A year-over-year to $725.0 in Q2 2021, while the trailing twelve-month figure through Dec 2021 was -$9000.0 (changed N/A YoY) and the FY2021 annual result came in at -$9000.0, down 107.76% from the prior year.
- Short-Term Debt issuances advanced to $725.0 in Q2 2021 per BJDX's latest filing, from -$9725.0 in the prior quarter.
- Over five years, Short-Term Debt issuances peaked at $725.0 in Q2 2021 and troughed at -$9725.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 64.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | -164.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.42 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -47.66 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -37.80 Mn |
| 10 | Bluejay Diagnostics | 1.89 Mn | 1.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 725.00 |
| Jun 30, 2021 | 725.00 |
| Mar 31, 2021 | -9,725.00 |
| Mar 31, 2021 | -9,725.00 |